Generic placeholder image

Current Drug Targets

Editor-in-Chief

ISSN (Print): 1389-4501
ISSN (Online): 1873-5592

Heme Oxygenase-1 and Iron in Liver Inflammation: A Complex Alliance

Author(s): Stephan Immenschuh, Eveline Baumgart-Vogt and Sebastian Mueller

Volume 11, Issue 12, 2010

Page: [1541 - 1550] Pages: 10

DOI: 10.2174/1389450111009011541

Price: $65

Open Access Journals Promotions 2
conference banner
Abstract

Heme oxygenase (HO)-1 is the inducible isoform of the first and rate-limiting enzyme of heme degradation. HO-1 has potent antioxidant and also anti-inflammatory functions, the underlying mechanisms of which are not well understood. Together with antioxidant carbon monoxide and biliverdin, HO produces reactive iron, which unambiguously connects this enzyme with the iron metabolism and its potential toxicity. A link between HO-1 and iron homeostasis has been demonstrated in HO-1 knockout mice, which develop major hemosiderosis in solid organs such as liver and kidney. Moreover, genetic HO-1 deficiency causes a chronic inflammatory condition in these animals. As the liver plays a crucial role for the bodys iron homeostasis (e.g. via secretion of the iron regulatory hormone hepcidin) and also for systemic inflammation, hepatic HO-1 may be important for the regulation of both systems. In particular, cell-specific functions of HO-1 in liver tissue macrophages (Kupffer cells) might be of major significance, because these cells play a key role in iron recycling during erythrophagocytosis and also in the control of hepatic and systemic inflammatory responses. This review discusses the current knowledge on interactions of HO-1 with iron metabolism in the context of systemic as well as hepatic inflammatory disorders. Recent advances in the understanding of the functional role of HO-1 in inflammatory liver diseases, namely viral hepatitis, alcoholic liver disease and non-alcoholic steatohepatitis are summarized. Finally, it is highlighted, how targeted modulation of HO-1 may provide specific protection in these inflammatory disorders.

Keywords: Antioxidant, heme oxygenase-1, hepcidin, inflammation, iron, liver, oxidative stress, isoform, anti-inflammatory, carbon monoxide, biliverdin, homeostasis, hemosiderosis, hormone hepcidin, Kupffer cells, viral hepatitis, alcoholic liver disease, non-alcoholic steatohepatitis, bilirubin (BR), reactive oxygen species (ROS), hemochromatosis, hepatocellular carcinoma (HCC), erythropoiesis, reticuloendothelial system (RES), iron regulatory protein (IRP)1, holoprotein, cytosolic aconitase, ferroportin (FRP), duodenal enterocytes, transferrin, alcoholic steatohepatitis, Hepcidin-dependent hypoferrem, Erythrophagocytosis, Kupffer cells (KCs), immunosensitized homologous, erythroid, toll-like receptor (TLR)-4, autophagy, phosphatidylinositol-3 kinase (PI3K)/Akt, aminoethyl-benzensulfonyl fluoride (AEBSF), microRNA-Mediated Strategies, hepatitis C virus, hepatoma cells, Alcoholic Liver Disease (ALD), pentoxyfyllin, Ginkgo biloba extract (GBE), aminotransferases, adiponectin, steatosis, steatohepatitis


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy